STOCK TITAN

Iveda (NASDAQ: IVDA) Q1 2026 results show higher revenue, cash boost from equity raise

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
10-Q

Rhea-AI Filing Summary

Iveda Solutions reported Q1 2026 revenue of $1.49 million, up slightly from $1.47 million a year earlier, driven mainly by higher Taiwan government project sales. Gross profit rose to $0.50 million, improving margin as cost of revenue fell. The company still posted a net loss of $0.53 million, narrower than the prior-year loss of $0.79 million, and used $0.9 million of cash in operations.

During the quarter Iveda raised net proceeds of about $1.6 million through a February 2026 equity offering, doubling common shares outstanding to 11.6 million and ending the period with $5.7 million in cash. Management concluded this cash should fund the operating plan for at least 12 months, though the company continues to carry an accumulated deficit and relies heavily on a few large Taiwan customers. Internal control over financial reporting and disclosure controls were assessed as not effective due to material weaknesses, which management is working to remediate.

Positive

  • None.

Negative

  • None.

Insights

Modest revenue growth, improved margins, but ongoing losses and control weaknesses.

Iveda delivered Q1 2026 revenue of $1.49 million, with most sales from Taiwan government contracts, and expanded gross profit to $0.50 million. Net loss improved to $0.53 million, helped by lower cost of goods and slightly reduced operating expenses.

The balance sheet strengthened as equity rose to $5.86 million and cash reached $5.70 million, mainly from a $1.6 million equity raise rather than operating cash flow. Dilution increased, with shares outstanding moving from 5.88 million to 11.59 million and 13.69 million warrants plus 0.73 million options outstanding.

Management’s going-concern analysis indicates existing cash should support at least 12 months of operations, but the business still depends on a small number of Taiwan customers and has material weaknesses in internal controls and disclosure controls. Future filings for periods after March 31, 2026 will show whether revenue growth and margin gains can offset ongoing cash burn.

Q1 2026 Revenue $1,494,174 Consolidated net revenue for the three months ended March 31, 2026
Q1 2026 Net Loss $532,831 Net loss for the three months ended March 31, 2026
Cash and equivalents $5,695,110 Cash, restricted cash and cash equivalents as of March 31, 2026
Total stockholders’ equity $5,864,259 Equity balance as of March 31, 2026
Common shares outstanding 11,594,027 shares Common stock issued and outstanding as of March 31, 2026
Warrants outstanding 13,691,641 warrants Outstanding and exercisable warrants at March 31, 2026
Options outstanding 732,142 options Stock options outstanding under all plans at March 31, 2026
Customer concentration 79% of revenue Top two Taiwan customers’ share of Q1 2026 revenue
Going Concern financial
"management has evaluated whether there are conditions and events... that raise substantial doubt about the Company’s ability to continue as a going concern"
A going concern is a business that is expected to continue its operations and meet its obligations for the foreseeable future, rather than shutting down or selling off assets. This assumption matters to investors because it indicates stability and ongoing profitability, making the business a more reliable investment. Think of it as believing a restaurant will stay open and serve customers, rather than closing down suddenly.
Revenue from Contracts with Customers financial
"The Company applies the provisions of Accounting Standards Codification (ASC) 606-10, Revenue from Contracts with Customers"
Stock-based compensation financial
"We recognized $12,000 and $0 of stock-based compensation expense for the three months ended March 31, 2026 and 2025"
Stock-based compensation is when a company pays employees, directors or consultants with shares or the right to buy shares instead of or in addition to cash. It matters to investors because issuing stock or options spreads ownership thinner (like cutting a pie into more slices), which can reduce each existing share’s claim on profits and can also change reported earnings; investors watch it to assess true cost of running the business and how management is incentivized.
Material weaknesses financial
"our internal control over financial reporting was not effective because of the following material weaknesses"
Material weaknesses are significant flaws in a company’s systems for ensuring its financial reports are accurate and reliable. Like a broken lock on a safe, they increase the chance that financial statements contain big errors or omissions, which can mislead investors about performance and risk; discovering one often raises questions about management oversight, may lead to restated results, and can affect investor confidence and a company’s valuation.
Smart city technologies technical
"Iveda offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms"
Fair value of financial instruments financial
"The Company uses various inputs in determining the fair value of its financial assets and liabilities"
The fair value of financial instruments is an estimate of what a bond, stock, loan or derivative would reasonably sell for right now in an open market, like the price a willing buyer and seller would agree on. Investors care because it tells them whether holdings are likely priced too high or low, affects reported profits and losses, and helps compare alternatives—think of it as a real‑time appraisal for financial assets.
Revenue $1,494,174 +1% year over year
Net loss $532,831 improved from $793,672 loss
Gross profit $495,208 +71% year over year
false --12-31 Q1 0001397183 0001397183 2026-01-01 2026-03-31 0001397183 IVDA:CommonStock0.00001ParValuePerShareMember 2026-01-01 2026-03-31 0001397183 IVDA:CommonStockPurchaseWarrantsMember 2026-01-01 2026-03-31 0001397183 2026-05-10 0001397183 2026-03-31 0001397183 2025-12-31 0001397183 2025-01-01 2025-03-31 0001397183 IVDA:EquipmentSalesMember 2026-01-01 2026-03-31 0001397183 IVDA:EquipmentSalesMember 2025-01-01 2025-03-31 0001397183 IVDA:ServiceRevenueMember 2026-01-01 2026-03-31 0001397183 IVDA:ServiceRevenueMember 2025-01-01 2025-03-31 0001397183 us-gaap:CommonStockMember 2024-12-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001397183 us-gaap:RetainedEarningsMember 2024-12-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001397183 2024-12-31 0001397183 us-gaap:CommonStockMember 2025-12-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001397183 us-gaap:RetainedEarningsMember 2025-12-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001397183 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001397183 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001397183 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001397183 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0001397183 us-gaap:CommonStockMember 2025-03-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001397183 us-gaap:RetainedEarningsMember 2025-03-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001397183 2025-03-31 0001397183 us-gaap:CommonStockMember 2026-03-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001397183 us-gaap:RetainedEarningsMember 2026-03-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:TwoCustomersMember 2026-01-01 2026-03-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:NationalChungShanMember 2026-01-01 2026-03-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:ChunghwaTelecomMember 2026-01-01 2026-03-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:TwoCustomersMember 2025-01-01 2025-03-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:NationalChungShanMember 2025-01-01 2025-03-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:ChunghwaTelecomMember 2025-01-01 2025-03-31 0001397183 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember IVDA:OneCustomersMember 2026-01-01 2026-03-31 0001397183 IVDA:CommercialEnterprisesMember 2026-01-01 2026-03-31 0001397183 IVDA:CommercialEnterprisesMember 2025-01-01 2025-03-31 0001397183 IVDA:DistributorsMember 2026-01-01 2026-03-31 0001397183 IVDA:DistributorsMember 2025-01-01 2025-03-31 0001397183 IVDA:MunicipalitiesMember 2026-01-01 2026-03-31 0001397183 IVDA:MunicipalitiesMember 2025-01-01 2025-03-31 0001397183 IVDA:TaiwanGovernmentMember 2026-01-01 2026-03-31 0001397183 IVDA:TaiwanGovernmentMember 2025-01-01 2025-03-31 0001397183 IVDA:HuaNamBankMember 2026-03-31 0001397183 IVDA:HuaNamBankMember 2025-12-31 0001397183 IVDA:HuaNamBankMember 2026-01-01 2026-03-31 0001397183 IVDA:HuaNamBankMember 2025-01-01 2025-12-31 0001397183 IVDA:ShanghaiBankMember 2026-03-31 0001397183 IVDA:ShanghaiBankMember 2025-12-31 0001397183 IVDA:ShanghaiBankMember 2026-01-01 2026-03-31 0001397183 IVDA:ShanghaiBankMember 2025-01-01 2025-12-31 0001397183 us-gaap:RevolvingCreditFacilityMember 2024-01-24 0001397183 IVDA:TermLoanMember 2024-01-24 0001397183 us-gaap:RevolvingCreditFacilityMember 2024-01-24 2024-01-24 0001397183 IVDA:TermLoanMember 2024-01-24 2024-01-24 0001397183 us-gaap:SeriesAPreferredStockMember 2026-03-31 0001397183 us-gaap:SeriesBPreferredStockMember 2026-03-31 0001397183 us-gaap:CommonStockMember 2024-09-17 2024-09-17 0001397183 2026-02-11 2026-02-11 0001397183 2026-02-11 0001397183 IVDA:SeriesXWarrantsMember 2026-02-11 0001397183 us-gaap:WarrantMember 2026-02-11 0001397183 IVDA:SeriesXWarrantsMember 2026-01-01 2026-03-31 0001397183 IVDA:TwoThousandTenStockOptionPlanMember 2010-01-18 0001397183 IVDA:TwoThousandTenStockOptionPlanMember 2011-12-31 0001397183 IVDA:TwoThousandTenStockOptionPlanMember 2010-01-18 2010-01-18 0001397183 IVDA:TwoThousandTenStockOptionPlanMember 2026-03-31 0001397183 IVDA:TwoThousandTenStockOptionPlanMember 2025-12-31 0001397183 IVDA:TwoThousandTwentyPlanMember srt:MaximumMember 2020-12-15 0001397183 IVDA:TwoThousandTwentyPlanMember 2025-01-01 2025-12-31 0001397183 IVDA:TwoThousandTwentyPlanMember 2024-01-01 2024-12-31 0001397183 IVDA:TwoThousandTwentyPlanMember 2026-03-31 0001397183 IVDA:TwoThousandTwentyPlanMember 2025-12-31 0001397183 IVDA:StockOptionPlanMember 2026-03-31 0001397183 IVDA:StockOptionPlanMember 2025-12-31 0001397183 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-03-31 0001397183 us-gaap:WarrantMember 2026-03-31 0001397183 srt:MinimumMember 2026-03-31 0001397183 srt:MaximumMember 2026-03-31 0001397183 us-gaap:WarrantMember 2026-01-01 2026-03-31 0001397183 us-gaap:WarrantMember 2026-01-01 2026-03-31 0001397183 us-gaap:WarrantMember 2025-01-01 2025-03-31 0001397183 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-03-31 0001397183 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0001397183 IVDA:MegasysMember 2026-01-01 2026-12-31 0001397183 us-gaap:OperatingSegmentsMember 2026-01-01 2026-03-31 0001397183 country:US 2026-01-01 2026-03-31 0001397183 country:TW 2026-01-01 2026-03-31 0001397183 us-gaap:OperatingSegmentsMember 2025-01-01 2025-03-31 0001397183 country:US 2025-01-01 2025-03-31 0001397183 country:TW 2025-01-01 2025-03-31 0001397183 country:CN 2026-01-01 2026-03-31 0001397183 country:CN 2025-01-01 2025-03-31 0001397183 country:US 2026-03-31 0001397183 country:US 2025-03-31 0001397183 country:CN 2026-03-31 0001397183 country:CN 2025-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:TWD IVDA:Segment

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2026

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to ____________

 

Commission File No. 001-41345

 

IVEDA SOLUTIONS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   20-2222203
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

1744 S Val Vista, Suite 213    
Mesa, Arizona   85204
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (480) 307-8700

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Securities registered pursuant to Section 12(g) of the Act: Common Stock, par value $0.00001 per share

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

  Large accelerated filer ☐ Accelerated filer ☐
  Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act): Yes ☐ No

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.00001 par value per share   IVDA   The Nasdaq Stock Market LLC
Common Stock Purchase Warrants   IVDAW   The Nasdaq Stock Market LLC

 

Class   Outstanding as of May 10, 2026
Common Stock, $0.00001 par value per share   11,594,027

 

 

 

 

 

 

TABLE OF CONTENTS

 

      Page
  PART I - FINANCIAL INFORMATION    
ITEM 1. FINANCIAL STATEMENTS   3
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS   18
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK   24
ITEM 4. CONTROLS AND PROCEDURES   24
  PART II - OTHER INFORMATION    
ITEM 1. LEGAL PROCEEDINGS   25
ITEM 1A. RISK FACTORS   25
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS   25
ITEM 3. DEFAULTS UPON SENIOR SECURITIES   25
ITEM 4. MINE SAFETY DISCLOSURES   25
ITEM 5. OTHER INFORMATION   25
ITEM 6. EXHIBITS   25
SIGNATURES   26

 

2
 

 

PART 1 – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS.

 

IVEDA SOLUTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   March 31, 2026   December 31, 2025 
   (UNAUDITED)     
ASSETS          
CURRENT ASSETS          
Cash and Cash Equivalents  $5,632,622   $5,156,252 
Restricted Cash   62,488    63,694 
Accounts Receivable, Net   745,311    256,699 
Deferred Cost of Goods   120,185    116,951 
Inventory, Net   247,974    235,958 
Other Current Assets   717,366    326,005 
Total Current Assets   7,525,946    6,155,559 
           
Property and Equipment, Net   41,147    47,093 
Right of Use Asset, Net   138,405    148,943 
Other Assets   152,993    76,195 
Total Assets  $7,858,491   $6,427,790 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
           
CURRENT LIABILITIES          
Accounts and Other Payables  $1,491,813   $938,560 
Short Term Debt   -    159,500 
Current Portion of Long-Term Debt   125,184    127,600 
Current Portion of Lease Liability   42,898    41,632 
Total Current Liabilities   1,659,895    1,267,292 
           
Long Term Debt   229,503    265,832 
Long Term Lease Liability, Net of Current Portion   104,834    114,904 
           
Total Liabilities   

1,994,232

    

1,648,028

 
           
STOCKHOLDERS’ EQUITY          
Preferred Stock, $0.00001 par value; 12,500,000 shares authorized, no preferred shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively   -    - 
Common Stock, $0.00001 par value; 300,000,000 shares authorized; 11,594,027 and 5,879,741 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively   117    59 
Additional Paid-In Capital   63,040,326    61,403,700 
Accumulated Other Comprehensive Loss   (268,524)   (249,168)
Accumulated Deficit   (56,907,660)   (56,374,829)
Total Stockholders’ Equity   5,864,259    4,779,762 
           
Total Liabilities and Stockholders’ Equity  $7,858,491   $6,427,790 

 

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

 

3
 

 

IVEDA SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

   For the Three
Months ended
March 31, 2026
   For the Three
Months ended
March 31, 2025
 
         
REVENUE          
Equipment Sales  $1,419,340   $1,408,732 
Service Revenue   74,834    65,844 
           
TOTAL REVENUE   1,494,174    1,474,576 
           
COST OF REVENUE   998,966    1,186,365 
           
GROSS PROFIT   495,208    288,211 
           
OPERATING EXPENSES          
General & Administrative   1,030,910    1,090,770 
Research & Development   30,000    33,000 
Total Operating Expenses   1,060,910    1,123,770 
           
LOSS FROM OPERATIONS   (565,702)   (835,559)
           
OTHER INCOME (EXPENSE)          
Miscellaneous Income (Expense)   6,141    32,422 
Interest Income   32,336    15,261 
Interest Expense   (5,606)   (5,796)
Total Other Income (Expense), Net   32,871    41,887 
           
NET LOSS  $(532,831)  $(793,672)
           
BASIC AND DILUTED LOSS PER SHARE  $(0.06)  $(0.28)
           
WEIGHTED AVERAGE SHARES   8,927,360    2,808,071 

 

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

 

4
 

 

IVEDA SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(UNAUDITED)

 

   For the Three
Months ended
March 31, 2026
  

For the Three

Months ended
March 31, 2025

 
         
Net Loss  $(532,831)  $(793,672)
Other Comprehensive Loss          
Change in Equity Adjustment from Foreign Currency Translation, Net of Tax   (19,356)   (10,880)
           
Comprehensive Loss  $(552,187)  $(804,552)

 

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

 

5
 

 

IVEDA SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(UNAUDITED)

 

                   Accumulated     
       Common   Additional       Other   Total 
   Common   Stock   Paid-in-   Accumulated   Comprehensive   Stockholders’ 
   Stock   Amount   Capital   Deficit   (Loss)   Equity 
                         
BALANCE AT December 31, 2024   2,808,071   $28   $55,962,337   $(53,176,717)  $(280,209)  $    2,505,439 
                               
Net Loss   -    -    -    (793,672)   -    (793,672)
Comprehensive Loss   -    -    -    -    (10,880)   (10,880)
BALANCE AT March 31, 2025   2,808,071   $28   $55,962,337   $(53,970,389)  $(291,089)  $1,700,887 
                               
BALANCE AT December 31, 2025   5,879,741   $59   $61,403,700   $(56,374,829)  $(249,168)  $4,779,762 
                               
Sale of Common Stock   5,714,286    58    1,624,626              1,624,684 
Stock Option Compensation             12,000              12,000 
Net Loss                  (532,831)        (532,831)
Comprehensive Loss                       (19,356)   (19,356)
BALANCE AT March 31, 2026   11,594,027   $117   $63,040,326   $(56,907,660)  $(268,524)  $5,864,259 

 

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements

 

6
 

 

IVEDA SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE THREE MONTHS ENDING MARCH 31, 2026 AND 2025 (UNAUDITED)

 

   March 31, 2026   March 31, 2025 
         
CASH FLOWS FROM OPERATING ACTIVITIES          
Net Loss  $(532,831)  $(793,672)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities          
Depreciation and Amortization   5,872    7,285 
Stock Compensation Expense   12,000    - 
Increase in allowance for uncollectible accounts   

20,000

    

 
Changes in operating assets and liabilities          
Accounts Receivable   (508,612)   457,885 
Inventory   (12,016)   (69,508)
Deferred Cost of Goods   (3,234)   147,920 
Right of Use Asset   10,538    3,314 
Other Current Assets   (386,488)   138,253 
Other Assets   (76,798)   12,704 
Increase in Accounts and Other Payables   553,253    (29,010)
Lease Liability   (8,804)   (1,137)
Net Cash Used in Operating Activities   (927,120)   (125,966)
           
CASH FLOWS FROM INVESTING ACTIVITIES          
Purchase of Property and Equipment   -    109 
Net Cash Used in Investing Activities   -    109 
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Payments on Short-Term Debt, net   (159,500)   - 
Proceeds from Short-Term Debt   -    37,909 
Proceeds from (Payments on) Long-Term Debt   (38,745)   (37,070)
Common Stock Issued, Net of Cost of Financing   1,624,684    - 
           
Net Cash Provided by Financing Activities   1,426,439    839 
           
EFFECT OF EXCHANGE RATE CHANGES ON CASH   (24,155)   (14,194)
           
NET DECREASE IN CASH, RESTRICTED CASH AND CASH EQUIVALENTS   475,164    (139,212)
           
Cash, Restricted Cash and Cash Equivalents- Beginning of Period   5,219,946    2,658,300 
           
CASH, RESTRICTED CASH AND CASH EQUIVALENTS - END OF PERIOD  $5,695,110   $2,519,088 

 

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

 

7
 

 

IVEDA SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - CONTINUED

FOR THE THREE MONTHS ENDING MARCH 31, 2026 AND 2025 (UNAUDITED)

 

   March 31, 2026   March 31, 2025 
         
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION          
Interest Paid  $2,525   $6,063 
Income Tax Paid  $-   $476 
           
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES          
Present Value of Right of Use Asset and Lease Obligations on New Lease  $-   $182,668 

 

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

 

8
 

 

IVEDA SOLUTIONS, INC.

 

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDING MARCH 31, 2026 AND 2025 (UNAUDITED)

 

NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Iveda Solutions, Inc. (“Iveda”, or the “Company”) was incorporated in Nevada as Charmed Homes, Inc. in June 2006. On October 15, 2009, IntelaSight, d/b/a Iveda, a Washington corporation, became a wholly owned subsidiary of the Company. In December 2010, IntelaSight merged with and into the Company and the Company became the surviving company. Iveda offered the first cloud hosting of streaming and recorded video from security cameras for its customers and real-time remote surveillance service utilizing intervention specialists to watch our customers’ cameras in real time, 24/7. Iveda offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide.

 

Consolidation

 

Effective April 30, 2011, we completed our acquisition of Sole Vision Technologies (fka MEGAsys and dba Iveda Taiwan), a company based in Taiwan. We consolidate our financial statements with the financial statements of Iveda Taiwan. All intercompany balances and transactions have been eliminated in consolidation.

 

Liquidity

 

The Company recorded a net loss of $0.5 million and used cash in operations of $0.9 million during the period ended March 31, 2026. During 2025, and subsequently, the Company took significant steps to raise capital to fund operations, and to reduce its historical operating losses. In accordance with Accounting Standards Codification (“ASC”) 205-40, Going Concern, the Company’s management has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying financial statements were issued. As of the issuance date of these financial statements, management expects that the Company’s cash of $5.7 million at March 31, 2026, will be sufficient to fund the Company’s current operating plan for at least twelve months from the date of issuance of these financial statements.

 

Management’s assessment whether there is sufficient cash on hand, together with expected capital raises, to assure operations for a period of at least twelve months from the date these financial statements are issued, is based on conditions that are known and reasonably knowable to management, considering various scenarios, projections, and estimates and certain key assumptions. These assumptions include, among other factors, management’s ability to increase operating efficiencies, raise additional capital, and the expected timing and nature of the Company’s forecasted cash expenditures.

 

Historically, the Company has financed its operations through public and private sales of common stock, credit lines from financial institutions, and cash generated from operations. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates. On an ongoing basis, we evaluate our estimates, including those related to accounts receivable, deferred cost of revenue, share-based compensation, deferred income taxes, provisions for losses, and inventory reserve, among other items.

 

Revenue and Expense Recognition

 

The Company applies the provisions of Accounting Standards Codification (ASC) 606-10, Revenue from Contracts with Customers, and all related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to its customers in an amount reflecting the consideration to which it expects to be entitled. In order to achieve that core principle, the Company applies the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.

 

9
 

 

The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with the customer. In situations where sales are to a distributor, the Company had concluded its contracts are with the distributor as the Company holds a contract bearing enforceable rights and obligations only with the distributor. As part of its consideration for the contract, the Company evaluates certain factors including the customers’ ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it expects to be entitled. As the Company’s standard payment terms are less than one year, it has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component. The Company allocates the transaction price to each distinct product based on its relative standalone selling price. The product price as specified on the purchase order is considered the standalone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar circumstances. Revenue is recognized when control of the product is transferred to the customer (i.e., when the Company’s performance obligations is satisfied), which typically occurs at shipment unless installation is required as with certain of our Taiwan sales – see below. Further in determining whether control has been transferred, the Company considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer. Customers do not have a right to return the product other than for warranty reasons for which they would only receive repair services or replacement product. The Company has also elected the practical expedient under ASC 340-40-25-4 to expense commissions for product sales when incurred as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.

 

The Company sells its products and services primarily to municipalities and commercial customers in the following manner:

 

  The majority of Iveda Taiwan sales are project sales to Taiwan customers and are made direct to the end customer (typically a municipality or a commercial customer) through its sales force, which is composed of its employees. Revenue is recorded when the equipment is shipped to the end customer unless the contract requires the inventory to be installed before it can be billed and charged for service when installation or maintenance work is performed. If inventory is shipped to the customer before it is installed the inventory is reclassified to Deferred Cost of Goods.

 

Revenue for product and software sales without installation is recorded when the product and/or software has been shipped to the customer. Revenue from fixed-price equipment installation contracts, if any, is recognized as the contracts allow for invoicing at various milestones.

 

General and administrative costs are charged to expense as incurred. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability may result in revisions to costs and income and are recognized in the period in which the revisions are determined. Changes in estimated job profitability resulting from job performance, job conditions, contract penalty provisions, claims, change orders, and settlements are accounted for as changes in estimates in the current period. Profit incentives are included in revenue when their realization is deemed earned by the contract.

 

  Iveda US hardware sales are to domestic and international independent distributors or integrators who purchase products from the Company at a wholesale price and sell to the end user (typically municipalities or a commercial customer) at a retail price. The Company will maintain product inventory and ship to the distributor or integrator or product is drop shipped from the manufacturer at the request of the Company to the distributor or integrator, and the Company at all times maintains the obligation to pay vendors and all related risks and rewards of ownership of customer receivables. Accordingly, upon application of steps one through five above, revenue is recorded when the product is shipped to the distributor or as directed by the distributor consistent with the terms of the distribution agreement.

 

  Iveda US also sells a one time software license to customers that allows them to activate software embedded in the purchased hardware. The software revenues are recorded as the license is delivered.
     
  Iveda US also sells hardware and software warranty and maintenance for an annual fee that are paid yearly. The revenues are recorded annually, if the revenue is a material amount it will be recorded as deferred revenue and amortized on a straight-line basis over the respective time period.

 

The Company sells and installs video surveillance systems comprised of various components of hardware and software.

 

The following table presents our net sales by revenue source and the period over period percentage change, for the period presented:

 

   For the three
months ended
March 31, 2026
   For three
months ended
March 31, 2025
 
         
Net Sales Source          
Commercial Enterprises  $503,430   $666,394 
Distributors  $23,482   $178,166 
Municipalities  $18,724   $18,131 
Taiwan Government  $948,538   $611,885 
           
 Net Sales Source  $1,494,174   $1,474,576 

 

The Company sells and installs video surveillance systems comprised of various components of hardware and software.

 

10
 

 

Concentrations

 

Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash and cash equivalents and trade accounts receivable.

 

Substantially all cash is deposited in three financial institutions, two in the United States and one in Taiwan. At times, amounts on deposit in the United States may be in excess of the FDIC insurance limit. Deposits in Taiwan financial institutions are insured by CDIC (Central Deposit Insurance Corporation) with maximum coverage of 3 million New Taiwan Dollar (NTD). At times, amounts on deposit in Taiwan may be in excess of the CDIC Insurance limit.

 

Revenue from two customers out of approximately 74 total customers represented approximately 79% of total revenue for the three months ended March 31, 2026. These specific customers were 1) National Chung Shan Institute of Science and Technology with 63%, 2) Chunghwa Telecom with 16% (both Taiwan companies). Revenue from two customers out of approximately 70 total customers represented approximately 58% of total revenue for the three months ended March 31, 2025. These specific customers were 1) National Chung Shan Institute of Science and Technology with 41% and 2) Chunghwa Telecom with 17% (both Taiwan companies).

 

No other customers represented greater than 10% of total revenues the three months ended March 31, 2026 and 2025.

 

84% of the total accounts receivable at March 31, 2026 was from one customer out of a total of 32 customer accounts receivable accounts. This specific customers was National Chung Shan Institute of Science and Technology. Our accounts receivables are unsecured, and we are at risk to the extent such amounts become uncollectible. Although we perform periodic evaluations of our customers’ credit and financial condition, we do not require collateral in exchange for our products and services provided on credit. These customers are longtime customers, and we don’t expect any problem with the collectability of these accounts receivable.

 

Cash and Cash Equivalents

 

For purposes of the statement of cash flows, we consider all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.

 

The Company’s consolidated financial statements include the results of operations and financial position of its subsidiary located in Taiwan. The subsidiary’s functional currency is the Taiwan New Dollar (TWD). For consolidation purposes, the subsidiary’s financial statements are translated into US Dollars (USD) using the following methods: Assets and liabilities are translated using the exchange rate at the balance sheet date. Income statement items are translated using the average exchange rate for the period. Exchange rate fluctuations between TWD and USD result in gains or losses that are included in Other Comprehensive Income (Loss) until they are realized. The Company had approximately $1 million and $1.4 million of its cash and cash equivalents in Taiwan New Dollars at March 31, 2026 and December 31, 2025, respectively.

 

Accounts Receivable

 

We provide an allowance for doubtful collections, which is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. For our U.S.-based segment, receivables past due more than 120 days, if any, are considered delinquent. For our Taiwan-based segment, receivables over one year, if any, are considered delinquent. Delinquent receivables are written off based on individual credit valuation and specific circumstances of the customer. There was no reserve necessary at March 31, 2026 or December 31, 2025.

 

Warrant Instruments

 

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own Common Stock and whether the instrument holders could potentially require net cash settlement in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and, for liability-classified warrants, at each reporting period end date while the warrants are outstanding.

 

Restricted Cash

 

Restricted cash represents time deposits on account to secure short-term bank loans in our Taiwan-based segment.

 

11
 

 

Stock-Based Compensation

 

The Company periodically issues stock, stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, Compensation-Stock Compensation whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services. The fair value of the Company’s stock options is estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods. We recognized $12,000 and $0 of stock-based compensation expense for the three months ended March 31, 2026 and 2025, respectively, related to the amortization of stock options.

 

Fair Value of Financial Instruments

 

The Company uses various inputs in determining the fair value of its financial assets and liabilities and measures these assets on a recurring basis. Financial assets recorded at fair value are categorized by the level of subjectivity associated with the inputs used to measure their fair value. Accounting Standards Codification Section 820 defines the following levels of subjectivity associated with the inputs:

 

Level 1—Quoted prices in active markets for identical assets or liabilities.

Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.

Level 3—Unobservable inputs in which there is little or no market data for the asset or liability which requires the Company to develop its own assumptions.

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to us as of March 31, 2026 and 2025. The respective carrying values of certain on-balance-sheet financial instruments approximate their fair values. These financial instruments include cash, accounts receivable, accounts payable, accrued expenses, and amounts due to related parties. Fair values were assumed to approximate carrying values for these financial instruments because they are short-term in nature and their carrying amounts approximate their fair values or because they are receivable or payable on demand. The carrying values of financing obligations approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.

 

New Accounting Standards

 

In November 2024, FASB issued ASU 2024-03 Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40) Disaggregation of Income Statement Expenses. The guidance in ASU 2024-03 requires public business entities to disclose in the notes to the financial statements, among other things, specific information about certain costs and expenses including purchases of inventory; employee compensation; and depreciation and amortization expense for each caption on the income statement where such expenses are included. The update is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted, and the amendments may be applied prospectively to reporting periods after the effective date or retrospectively to all periods presented in the financial statements. We are currently evaluating the provisions of this guidance and assessing the potential impact on our financial statement disclosures.

 

Other recent accounting pronouncements and guidance issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

 

12
 

 

NOTE 2 Accounts and Other Payables

 

 SCHEDULE OF ACCOUNTS AND OTHER PAYABLES

   March 31, 2026   December 31, 2025 
         
Accounts Payable  $876,327   $459,308 
Accrued Expenses   302,331    479,057 
Deferred Revenue and Customer Deposits   313,155    195 
Accounts and Other Payables  $1,491,813   $938,560 

 

NOTE 3 SHORT-TERM AND LONG-TERM DEBT

 

The short-term debt balances were as follows:

 

   March 31, 2026   December 31, 2025 
         
Loan from HuaNam Bank at 3.45% interest rate per annum. Due in July 2026.   -    159,500 
Loan from HuaNam Bank at 3.45% interest rate per annum. Due in July 2026.   -    159,500 
Balance at end of period  $-   $159,500 

 

The Company repaid the outstanding loan balance during the period ended March 31, 2026, and there are no further obligations due to this bank.

 

The Long-term debt balances were as follows:

 

Loans from Shanghai Commercial Bank with interest rates 2.1% per annum due January 2029 (1)  $354,687   $393,432 
Loans from Shanghai Commercial Bank with interest rates 2.1% per annum due January 2029 (1)  $354,687   $393,432 
Current Portion of Long-term debt   (125,184)   (127,600)
Balance at end of period  $229,503   $265,832 

 

On January 24, 2024, the Company received a facility notice from Shanghai Commercial Bank, granting a revolving loan facility totaling up to TWD 10,000,000 (approximately $300,000 USD) and term loan facility amounting of TWD 20,000,000 (approximately ($600,000 USD). The term for the revolving loan is 1 year and for the term loan is 5 years. The 5 year term loan requires monthly payments including interest and principal, and the revolving loan requires a full principal repayment at the maturity date. The guarantors of this loan are Mr. Siu and Mr. Cheung, who are both part of Iveda Taiwan’s management team.

 

As of March 31, 2026, and December 31, 2025, there was $62,488 and $63,694, respectively, of restricted cash pledged as security for the Shanghai Commercial Bank long term loan.

 

NOTE 4 PREFERRED STOCK

 

We are currently authorized to issue up to 12,500,000 shares of preferred stock, par value $0.00001 per share, 1,250,000 shares of which are designated as Series A Preferred Stock and 500 shares of which are designated as Series B Preferred Stock. Our Articles of Incorporation authorize the issuance of shares of preferred stock with designations, rights, and preferences determined from time to time by our Board of Directors. Accordingly, our Board of Directors is empowered, without stockholder approval, to issue preferred stock with dividend, liquidation, conversion, voting, or other rights which could adversely affect the voting power or other rights of the stockholders of our common stock. In the event of issuance, the preferred stock could be utilized, under certain circumstances, as a method of discouraging, delaying, or preventing a change in control of our company.

 

NOTE 5 EQUITY

 

Common Stock

 

We are authorized to issue up to 300,000,000 shares of common stock, par value $0.00001 per share. We effectuated a reverse stock split on September 17, 2024 of 1 for 8 shares of common stock. All share values within this report have been retroactively adjusted to the post reverse split values. All outstanding shares of our common stock are of the same class and have equal rights and attributes. The holders of our common stock are entitled to one vote per share on all matters submitted to a vote of the stockholders of our company. Our common stock does not have cumulative voting rights. Persons who hold a majority of the outstanding shares of our common stock entitled to vote on the election of directors can elect all of the directors who are eligible for election. Holders of our common stock are entitled to share equally in dividends, if any, as may be declared from time to time by our Board of Directors. In the event of liquidation, dissolution, or winding up of our company, subject to the preferential liquidation rights of any series of preferred stock that we may from time to time designate, the holders of our common stock are entitled to share ratably in all of our assets remaining after payment of all liabilities and preferential liquidation rights. Holders of our common stock have no conversion, exchange, sinking fund, redemption, or appraisal rights (other than such as may be determined by the Board of Directors in its sole discretion) and have no preemptive rights to subscribe for any of our securities.

 

On February 11, 2026, Iveda Solutions, Inc., a Delaware corporation (the “Company”) consummated a public offering (the “Offering”) for aggregate gross proceeds of approximately $2 million before deducting placement agent fees and other offering expenses payable by the Company. Net proceeds to the Company after the payment of all costs was $1.6 Million. The Offering included (i) 5,259,999 shares (the “Shares”) of the Company’s common stock, par value $0.00001 per share (“Common Stock”) at an offering price of $0.35 per share of Common Stock, and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 454,287 shares of Common Stock, at an offering price of $0.3499 per Pre-Funded Warrant and (iii) accompanying series X warrants (the “Series X Warrants”) to purchase up to 11,428,572 shares of Common Stock.and accompanying Series X Warrant.

 

The Pre-Funded Warrants are immediately exercisable subject to certain ownership limitations, have an exercise price of $0.0001 per share, and may be exercised at any time until all of the Pre-Funded Warrants have been exercised in full. The Series X Warrants are exercisable at a price of $0.35 per share, are exercisable from and after the date of their issuance and expire on the second (2)-year anniversary of the original issuance date. All of the pre-funded warrants were exercised during the period ended March 31, 2026 resulting in an aggregate issuance of 5,714,286 shares of common stock from the offering.

 

In addition, the Company issued two year placement agent warrants to purchase 400,000 shares of common stock at an exercise price of $0.4375 per share.

 

13
 

 

NOTE 6 STOCK OPTION PLANS

 

Stock Options

 

On January 18, 2010, we adopted the 2010 Stock Option Plan (the “2010 Option Plan”), which allows the Board to grant options to purchase up to 15,625 shares of common stock to directors, officers, key employees, and service providers of our company. In 2011, the 2010 Option Plan was amended to increase the number of shares issuable under the 2010 Option Plan to 375,000 shares. In 2012, 2010 Option Plan was again amended to increase the number of shares issuable under the 2010 Option Plan to 203,125 shares. The shares issuable pursuant to the 2010 Option Plan are registered with the SEC under Forms S-8 filed on February 4, 2010 (No. 333- 164691), June 24, 2011 (No. 333-175143), and December 4, 2013 (No. 333-192655). The 2010 Option Plan expired on January 18, 2020. As of March 31, 2026 there were 14,308 options outstanding under the 2010 Option Plan and as of December 31, 2025 there were 14,778 options outstanding under the 2010 Option Plan.

 

On December 15, 2020, we adopted the Iveda Solutions, Inc. 2020 Plan (the “2020 Plan”). The 2020 Plan had a maximum of 156,250 shares authorized with similar terms and conditions to the 2010 Option Plan. The shares issuable pursuant to the 2020 Option Plan are registered with the SEC under Forms S-8 filed on October 7, 2022 (No. 333- 267792). In 2025 and 2024, the 2020 Option Plan was amended to increase the number of shares issuable under the 2020 Option Plan to 1,156,250 and 656,250 shares, respectively. As of March 31, 2026 there were 717,834 options outstanding under the 2020 Option Plan. As of December 31, 2025 there were 720,959 options outstanding under the 2020 Option Plan.

 

As of March 31, 2026 and December 31, 2025, there were 732,142 and 735,737 options outstanding, respectively, under all the option plans.

 

Stock options may be granted as either incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), or as options not qualified under Section 422 of the Code. All options are issued with an exercise price at or above the fair market value of the common stock on the date of the grant as determined by our Board of Directors. Incentive stock option plan awards of restricted stock are intended to qualify as deductible performance-based compensation under Section 162(m) of the Code. Incentive Stock Option awards of unrestricted stock are not designed to be deductible to us under Section 162(m). Under the plans, stock options will terminate on the tenth anniversary date of the grant or earlier if provided in the grant.

 

We have also granted non-qualified stock options to employees and contractors. All non-qualified options are generally issued with an exercise price no less than the fair value of the common stock on the date of the grant as determined by our Board of Directors. Options may be exercised up to ten years following the date of the grant, with vesting schedules determined by us upon grant. Vesting schedules vary by grant, with some fully vesting immediately upon grant to others that ratably vest over a period of time up to four years. Standard vested options may be exercised up to three months following date of termination of the relationship unless alternate terms are specified at grant. The fair values of options are determined using the Black-Scholes option-pricing model. The estimated fair value of options is recognized as expense on the straight-line basis over the options’ vesting periods.. During the three months ended March 31, 2026, the Company repriced 535,000 which resulted in an incremental compensation cost of $12,000 that was recorded during the period.

 

Stock option transactions during three months ended March 31, 2026 were as follows:

 

   March 31, 2026 
   Shares   Weighted-
Average
Exercise Price
 
         
Outstanding at Beginning of Period   735,737    5.50 
Granted   -    - 
Exercised   -    - 
Forfeited or Cancelled   (3,595)   6.90 
Outstanding at End of Period   732,142    5.11 
Options Exercisable at Period-End   730,267   $5.12 

 

During the three months ended March 31, 2026 and 2025 the Company recognized $12,000 and $0 of compensation cost relating to the vesting of options.

 

    Options Outstanding   Options Exercisable 
Range of
Exercise
Prices
   Number
Outstanding at
March 31,
2026
   Weighted-
Average
Remaining
Contractual
Life
   Weighted-
Average
Exercise
Price
   Number
Exercisable at
December 31,
2025
   Weighted-
Average
Exercise
Price
 
$ 0.29-142.08     732,142    8.9   $5.11    730,267   $5.12 

 

14
 

 

The Black-Scholes option pricing model, used to estimate fair value of the option awards, requires the use of the following assumptions:

 

● Fair value of common stock. The fair value of the common stock is the Company’s closing price per share on the NASDAQ listing at the grant date.

 

● Expected Term. The expected term of options granted represents the period of time that the options are expected to be outstanding. Due to the lack of historical exercise history, the expected term of the Company’s stock options has been determined by calculating the midpoint of the contractual term of the options and the weighted-average vesting period.

 

● Expected Volatility. The expected stock price volatility assumption was determined by examining the historical volatilities for industry peers, as the Company did not have any trading history for the common stock. The Company will continue to analyze the historical stock price volatility and expected term assumption as more historical data for the common stock becomes available.

 

● Risk-Free Interest Rate. The risk-free interest rate assumption is based on the U.S. Treasury instrument whose term was consistent with the expected term of the Company’s stock options.

 

● Dividends. The Company has not paid any cash dividends on common stock since inception and does not anticipate paying any dividends in the foreseeable future. Consequently, an expected dividend yield of zero was used.

 

The fair value of options granted was estimated using the Black-Scholes valuation model using the following assumptions for the three months ended March 31, 2026:

 

   Three months ended
March 31, 2026
 
Expected volatility   136%
Expected dividend yield   %
Expected term (in years)   4.92 
Risk-free interest rate   4.0%

 

There was no intrinsic value of the outstanding options at March 31, 2026.

 

NOTE 7 WARRANTS

 

Warrants

 

Warrant transactions during the Three Months ended March 31, 2026 were as follows:

 

   For the Three Months ended
March 31, 2026
 
   Shares   Weighted-Average
Exercise Price
 
         
Outstanding at Beginning of Period   1,863,069   $9.13 
Granted   11,828,572    0.35 
Exercised   -   - 
Forfeited or Cancelled   -    - 
Outstanding at End of Period   13,691,641    1.55 
Warrant Exercisable at Period-End   13,691,641    1.55 
Weighted-Average Fair Value of Warrants Granted During the Period  $0.18      

 

Information with respect to warrants outstanding and exercisable at March 31, 2026 is as follows:

 

      Warrants Outstanding         Warrants Exercisable 
 

Range of

Exercise Prices

    

Number

Outstanding at

March 31, 2026

    

Weighted-

Average Remaining Contractual

Life

    

Weighted-

Average

Exercise Price

    

Number

Exercisable at

March 31, 2026

    

Weighted-

Average

Exercise Price

 
$0.35 -$34.00   13,691,641    1.9   $1.55    13,691,641   $1.55 

 

There was no intrinsic value of the outstanding warrants at March 31, 2026.

 

15
 

 

NOTE 8 EARNINGS (LOSS) PER SHARE

 

Basic earnings per share (“EPS”) is computed by dividing reported earnings available to stockholders by the weighted average shares outstanding. We had net losses for the three months ended March 31, 2026 and 2025 and the effect of including dilutive securities in the earnings per common share would have been anti-dilutive for the purpose of calculating EPS. Accordingly, all options, warrants, and shares potentially convertible into common shares were excluded from the calculation of diluted earnings per share for the periods ended March 31, 2026 and 2025.

 

   March 31, 2026   March 31, 2025 
         
Basic EPS          
Net Loss  $(532,831)  $(793,672)
Weighted Average Shares   8,927,360    2,808,071 
Basic Loss Per Share  $(0.06)  $(0.28)

 

For the three months ended March 31, 2026 and 2025, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following:

 

   March 31, 2026   March 31, 2025 
Warrants   13,691,641    1,863,069 
Options   732,142    214,819 
Total   14,423,783    2,077,888 

 

NOTE 9 COMMITMENTS AND CONTINGENCIES

 

The Company may be involved in certain legal proceedings that arise from time to time in the ordinary course of our business. Except for income tax contingencies, we record accruals for contingencies to the extent that our management concludes that the occurrence is probable and that the related amounts of loss can be reasonably estimated. Management believes the accompanying financial statements include all provisions, of any, for any potential losses. Legal expenses associated with the contingency are expensed as incurred.

 

Pursuant to certain contracts with Chicony Power Technology Co., Ltd., Shihlin Electric & Engineering Corporation, National Chung Shan Institute of Science and Technology and Chung-Hsin Electric and Machinery Manufacturing Corp., Iveda Taiwan is required to provide after-project services. If Iveda Taiwan fails to provide these after-project services in the future, other parties of the related contract would have recourse. The financial exposure to Iveda Taiwan in the event of failure to provide after- project services in the future as of March 31, 2026 is $361,953.

 

NOTE 10 SEGMENT INFORMATION

 

The Company operates and manages its business as two reportable and operating segments. The Company’s CODM reviews financial information presented and decides how to allocate resources based on net income (loss). Net income (loss) is used for evaluating financial performance.

 

Significant segment expenses include salaries and payroll, marketing, public company expenses, audit and accounting, consulting, research and development, travel and entertainment, software subscription and other administrative expenses for the US and salaries and payroll, rent, travel and entertainment, and other administrative expenses. The following table presents the significant segment expenses and other segment items regularly reviewed by our CODM.

 

                   
   Three Months Ended March 31, 2026   Three Months Ended March 31, 2025 
   Consolidated   US   Taiwan   Consolidated   US   Taiwan 
Revenues  $1,494,174   $23,482   $1,470,692   $1,474,576   $238,426   $1,236,150 
Cost of Goods Sold   998,966    24,186    974,780    1,186,365    183,628    1,002,737 
Gross Profit   495,208    (704)   495,912    288,211    54,798    233,413 
    33%   (3%)  34%   20%   23%   19%
                               
Operating Expenses                              
Salaries and Payroll Expenses   348,453    234,190    114,264    344,210    253,965    90,245 
Travel and Entertainment   65,443    54,664    10,779    142,578    129,964    12,614 
Marketing   106,476    106,476    -    76,255    76,255    - 
Public Company expenses   61,705    61,705    -    57,076    57,076    - 
Audit and Accounting   90,087    90,087    -    167,883    167,883    - 
Research and Development   30,000    30,000    -    33,000    33,000    - 
Rent   37,256    24,306    12,951    35,006    22,915    12,091 
Other operating expenses   321,488    257,774    63,714    267,762    200,755    67,007 
Total Operating Expenses   1,060,910    859,202    201,708    1,123,770    941,813    181,957 
Income (Loss) from Operations   (565,702)   (859,908)   294,204    (835,559)   (887,015)   51,456 
Interest Income and Other (Expenses), net   32,871    26,981    5,890    41,887    39,141    2,746 
Net loss  $(532,831)  $(832,925)  $300,094   $(793,672)  $(847,874)  $54,202 

 

16
 

 

Furthermore, due to operations in various geographic locations, we are susceptible to changes in national, regional, and local economic conditions, demographic trends, consumer confidence in the economy, and discretionary spending priorities that may have a material adverse effect on our future operations and results.

 

We are required to collect certain taxes and fees from customers on behalf of government agencies and remit them back to the applicable governmental agencies on a periodic basis. The taxes and fees are legal assessments to the customer, for which we have a legal obligation to act as a collection agent. Because we do not retain the taxes and fees, we do not include such amounts in revenue. We record a liability when the amounts are collected and relieve the liability when payments are made to the applicable governmental agencies.

 

The Net Revenues for our significant geographic regions are as follows:

  

         
   Net Revenues 
   For the
Three Months ended
   For the
Three Months ended
 
   March 31, 2026   March 31, 2025 
United States  $23,482   $238,426 
Republic of China (Taiwan)  $1,470,692   $1,236,150 
Total Consolidated  $1,494,174   $1,474,576 

 

The net assets (liabilities) for our significant geographic regions are as follows:

 

         
   Net Assets (Liabilities) 
   As of   As of 
   March 31, 2026   December 31, 2025 
United States  $4,722,729   $3,918,970 
Republic of China (Taiwan)  $1,141,530   $860,792 
          
Total Consolidated  $5,864,259   $4,779,762 

 

NOTE 11 SUBSEQUENT EVENTS

 

The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the financial statements are available to be issued. Any material events that occur between the balance sheet date and the date that the financial statements were available for issuance are disclosed as subsequent events, while the financial statements are adjusted to reflect any conditions that existed at the balance sheet date.

 

17
 

 

Item 2. Financial Information.

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and associated notes appearing elsewhere in this Form 10-Q Quarterly Report.

 

Note Regarding Forward-Looking Information

 

This Report on Form 10-Q Quarterly Report contains forward-looking statements that involve risks and uncertainties. All statements other than statements of historical fact contained in this Form 10-Q Quarterly Report, including statements regarding future events, our future financial performance, business strategy, and plans and objectives for future operations, are forward-looking statements. In many cases, you can identify forward-looking statements by terminology such as “anticipates,” “believes,” “can,” “continue,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “should,” or “will” or the negative of these terms or other comparable terminology. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including the risks outlined under “Risk Factors”, “Liquidity and Capital Resources” with respect to our ability to continue to generate cash from operations or new investment, or elsewhere in this Report on Form 10-Q Quarterly Report or discussed in our consolidated financial statements for the year ended December 31, 2025, which may cause our or our industry’s actual results, levels of activity, performance, or achievements to differ materially from those expressed or implied by these forward-looking statements. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time, and it is not possible for us to predict all risk factors, nor can we address the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause our actual results to differ materially from those contained in any forward-looking statements.

 

Overview

 

Iveda offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years.

 

A new report from Verified Market Research projects that the global smart city platforms market size will grow at a CAGR of 9% from 2026 to 2032, increasing from USD 208.8 billion to USD 416.1 billion. Meanwhile, Fortune Business Insights reports that the global IoT market—valued at USD 308.97 billion in 2020—expanded by 23.1% that year, substantially outpacing the average annual growth rate from 2017 to 2019. Looking ahead, IoT is expected to surge from USD 381.30 billion in 2021 to USD 1,854.76 billion in 2028.

 

Additionally, the International Data Corporation (IDC) projects that global spending on artificial intelligence will double from USD 50.1 billion in 2020 to over USD 110 billion in 2024. These trends underscore the rising demand for connected solutions and highlight the promising future of innovative technologies that enhance the safety and efficiency of urban environments. With its cutting-edge products and global reach, Iveda is uniquely positioned to lead this transformation, providing the advanced solutions that cities need to move forward smartly and securely.

 

Technology / Products

 

Iveda offers AI intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).

 

IvedaAI

 

IvedaAI consists of deep-learning video analytics software running in a computer/server environment that can either be deployed at an edge level or data center for centralized cloud model. We combined hardware and artificial intelligence software for fast and efficient video search for objects stored in an external (NVR) or storage device and live streaming video data from any IP camera.

 

IvedaAI works with any ONVIF-compliant IP cameras and most popular NVR/VMS (Video Management System) platforms, enabling accurate search across dozens to thousands of cameras in less than 1 second. IvedaAI products are designed to maximize efficiency, save time, and cut cost. Instead of watching hours of video recording after-the-fact, users can set up alerts.

 

AI Functions

 

  Object Search
  Face Search (No Database Required)
  Face Recognition (from a Database)
  License Plate Recognition (100+ Countries), includes make and model
  Intrusion Detection
  Weapon Detection
  Fire Detection
  People Counting
  Vehicle Counting
  Temperature Detection
  Public Health Analytics (Facemask Detection)
  QR and Barcode Detection

 

18
 

 

Key Features

 

  Live Camera View
  Live Tracking
  Abnormality Detection – Vehicle/Person wrong direction detection
  Vehicle/Person Loitering Detection
  Fall Detection
  Illegal Parking Detection
  Heatmap Generation

 

IvedaAI consists of deep-learning video analytics software running in a computer/server environment that can either be deployed at an edge level or data center for centralized cloud model. We combined hardware and artificial intelligence software for fast and efficient video search for objects stored in an external (NVR) or storage device and live streaming video data from any IP camera.

 

IvedaAI works with any ONVIF-compliant IP cameras and most popular NVR/VMS (Video Management System) platforms, enabling accurate search across dozens to thousands of cameras in less than 1 second. IvedaAI products are designed to maximize efficiency, save time, and cut cost. Instead of watching hours of video recording after-the-fact, users can set up alerts.

 

Iveda offers many IoT sensors and devices for various applications, such as energy management, smart home, smart building, smart community and patient/elder care. Our gateway and station serve as the main hub for sensors and devices in any given area. They are equipped with high-level communication protocols such as Zigbee, WiFi, Bluetooth, and USB. They connect to the Internet via Ethernet or cellular data network. We provide IoT platforms that enable centralized device management and push digital services on a massive scale. Our smart devices include water sensor, environment sensor, entry sensor, smart plug, siren, body temperature pad, a care wrist watch and tracking devices.

 

We also offer smart power technology for office buildings, schools, shopping centers, hotels, hospitals, and smart city projects. Our smart power hardware is equipped with an RS485 communication interface allowing the meters to be connected to various third-party SCADA (supervisory control and data acquisition) software for monitoring and control purposes. This line of product includes smart power, water meter, smart lighting controls systems, and smart payment system.

 

Iveda’s Cerebro is a software technology platform that integrates a multitude of disparate systems for central access and management of applications, subsystems, and devices throughout an entire environment. It is system agnostic and will support cross-platform interoperability. Cerebro’s roadmap includes a dashboard for all of Iveda’s platforms for central management of all devices. It provides remote access to a Dashboard for a single user interface, providing convenient anywhere, anytime access and analysis of relevant information in a timely manner for managing an entire organization or city. Cerebro links city systems and subsystems inseparably to each other. This integration and unification of all subsystems enable acquisition and analysis of all information on one central entity allowing comprehensive, effective and overall management and protection of a city.

 

IvedaSPS is our smart power solution, utilizing our Cerebro IoT platform. This completes our digital transformation solution crucial in smart city deployments as well as in large organizations. We offer smart power technology for office buildings, schools, shopping centers, hotels, hospitals, and smart city projects. This product includes smart power, water meter, smart lighting controls systems, and smart payment system.

 

In the last few years, smart city has been a hot topic among cities across the globe. With little to no human interaction, technology increases efficiency, expedites decision making, and reduces response time. Dwindling public safety budgets and resources have necessitated this transformation. More and more municipalities are using next-generation technologies to improve the safety and security of its citizens. Our response is our complete suite of IoT technologies, including AI intelligent video search technology, smart sensors, tracking devices, video surveillance systems, and smart power.

 

19
 

 

Utilus is our smart pole solution, utilizing our Cerebro IoT platform. This completes our digital transformation solution crucial in smart city deployments as well as in large organizations. Iveda leverages infrastructure already available in most modern cities – Light poles with power We equip existing poles with Utilus. Utilus consists of power and Internet, establishing a communication network for access and management of sensors and devices that the city requires to keep its citizens safe and secure and to effectively manage utility consumption. Our smart pole offering is also ideal for:

 

  Government or large-scale city deployments
  Supporting and Improving City Services
  Reducing Emergency Response Times
  Crime& Hazard Protection
  Monitoring and Improving Air Quality
  Sound Detection
  Traffic Monitoring and Mobility as a Service
  Data Analytics and Monetization Opportunities

 

vumastAR is an AI vision software that uses video taken on IP cameras, AR glasses, Androids, and tablets to analyze and process data in real-time. vumastAR is fully customizable to the user’s needs, with one short video the AI can be trained in as little as two hours. Deployable in multiple industries for uses such as:

 

  Quality and Maintenance Exams: vumastAR has the power to assist with critical measuring of carcinogenic chemical compound levels, electrical wiring, and welding inspections.
  Factory and Line Work: Fast and accurate machine recognition enables itemized counting, inventory audits, and assembly kitting.
  Pharma: Accurately identify and quantify medication, greatly reducing the manual labor of counting pills while eliminating human error.
  Supply Chain: Detect defects and anomalies for improved accuracy, increasing the bottom line by actively reducing lost revenue incurred from manual mistakes.
  Manufacturing: Digitalize meter and gauge reading and monitoring, as well as part number identification, with the ability to turn analog information into digital data
  Transportation: Enhance safety and security for operations including loading and unloading tanker trucks, protecting both personnel and products/equipment.
  Retail: Ensure correct item identification and organization, providing increased accuracy for retail checkout and product categorization, ultimately impacting revenue streams.

 

vumastAR is sold as a license per device with a monthly subscription requirement for cloud access to trained AI models.

 

IvedaXpress is a system that enables users to use pre-existing IP cameras and apply AI analytics without the need for large servers or a dedicated IT department. Designed to be plug-and-play IvedaXpress provides a hassle free set up process with no maintenance required for hardware. Each IP camera is hosted from a local computer or smartphone for live viewing and playback. Video may be stored on that local computer or stored remotely using free storage from Amazon or Dropbox.

 

Iveda Smart UVC is a Commercial-grade, AI-driven Ultraviolet Germicidal Irradiation (UVGI). Iveda Smart UVC adds UV lights to standard HVAC vents for quick, easy, and inexpensive deployment to homes and commercial buildings. Leveraging the existing air circulation system, Iveda Smart UVC vents disinfect the air by irradiating UV light on the passing air. Eliminating the need to manually disinfect offices, meeting rooms, and other workspaces. Iveda Smart UVC can be Integrated with Iveda SPS (smart power management) and sensors to efficiently and effectively operate the light source upon detected movement.

 

20
 

 

Iveda’s Smart Drones are flown to perform certain functions from an aerial view without the need for a pilot onboard. Smart Drones utilize AI-based software for autonomous operation and navigation from taking off, returning to base, carrying out mission-critical tasks or simply doing an aerial patrol, without the need of human intervention. Unlike typical drones, Iveda Smart Drones are cloud-based and can be part of a network of drones for central management. They are equipped with Iveda’s Sentir Video Surveillance System and IvedaAI Intelligent Video Search Technology.

 

Iveda Smart Drone product offering is robust and expansive for a multitude of industrial, commercial, and military applications.

 

Key Features of Iveda’s Smart Drone:

 

Fully Autonomous

Scheduled autonomous take-off, flight mission execution, monitoring, landing and recharging

Easy operation and 24-7 flight mission

 

Intelligent Computing

Live video streaming - real-time object recognition and tracking

Onboard (edged) AI and data analysis

 

Safety Design

Multiply redundant and fail-safe systems

Weather resistant industrial grade systems (IP54)

Designed and made in Taiwan (MIT)

 

Skywatch

Planning and editing real-time/timed missions

User/Group permission control & flight data management

Failsafe alarm and FPV gimbal control

 

Insight

Automated orthorectified service of imagery (2D/3D)

AI technology for inspecting natural disaster, vehicle & pedestrian tracking, and energy facilities inspection.

Visualizing geographic data and analysis report

 

  Propellers: 8 (multiply redundant)
  Diagonal Footprint: 29.76″ / 756 mm
  Weight: 14.1lbs / 6.4 Kg
  Hover time: 30 mins
  Wind tolerance: Beaufort scale – 6
  IP rating: IP54
  Camera sensor: Dual RGB, IR/thermal
  Network: 5G/4G LTE and 2.4G Wi-Fi

 

The Smart Utility Cabinet gives end users a convenient tool to monitor their daily energy consumption, to pinpoint electrical leaks, and to prevent power line overload and potential fire. It utilizes IoT sensors to detect abnormalities in consumption, temperature and tampering. Iveda Smart Utility Cabinet has an internal environment control design, housed in a durable industrial-grade cabinet. It includes a smart edge computing gateway with multi-RF communication protocols such as 4G, Z-Wave and WiFi and tampering sensor for unauthorized access. Smart water meter and gas meter may be added to the Cabinet.

 

Vemo Body Camera streams live video, using 4G, to headquarters and doubles as a walkie talkie with a push-to-talk feature. With its multi-mode audio, it can also be used for broadcasting and hands-free audio conferencing for group talk. Vemo has WiFi capability which is ideal for city-wide deployments. Vemo transmits live streaming video instantaneously to the cloud without additional software or hardware. Vemo’s cloud management platform can centrally manage an unlimited number of devices and video can be accessed on a PC, Android, and iOS client. Moreover, Vemo can stream directly into the IvedaAI platform for real-time video analytics to search for faces, objects or license plates in real time.

 

IvedaCare, launched in November 2022, is a simple, easy to use suite of wireless health and wellness devices intended to help you monitor the health and activities of your loved ones, even when you can’t be there yourself. Our mission is to help ensure your loved one’s safety and independence. Stay connected to your elderly loved ones with our advanced IoT devices for real-time monitoring, fall detection, medication reminders and more. With IvedaCare, you not only can monitor your home and loved ones from afar but can potentially make life-saving decisions using the app. Cloud-based, wireless sensors collect real-time data shared with the entire family circle within the app. Customers may add a subscription service for Pro Monitoring. If the Trusted Circle is unavailable, our emergency call center will dispatch emergency services quickly.

 

21
 

 

LevelNOW is an advanced IoT-based solution that transforms the way liquid levels are monitored and managed. With two unique IoT sensors—a standard cap valve sensor designed for 200-liter drums and a patent- pending external sensor that fits various container sizes—LevelNOW provides real-time data to ensure efficiency, safety, and cost savings. Its user-friendly AI-backed platform optimizes operations for industries that rely on large fluid containers, such as oil, gas, and industrial storage. Know exactly when customers are running low and deploy fleets in real time to refill your liquids.

 

Customers

 

Our business model in the US is to primarily sell hardware and license our software to organizations already providing services to an existing customer base and facilitating hardware acquisition through third party partners. This business model provides dual revenue streams – one from surveillance camera and analytics hardware sales to the service providers and the other from software licensing fees.

 

Iveda Taiwan continues to service its enterprise and government clients on a per-project basis. Some of its customers include Chunghwa Telecom, the Taiwan Stock Exchange, New Taipei City Police Department, Chicony Power Technology Co, Ltd. and Taiwan Energy Systems.

 

Critical Accounting Policies and Estimates

 

Management’s Discussion and Analysis of Financial Conditions and Results of Operations is based upon our financial statements, which have been prepared in accordance with GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions. A description of our critical accounting policies and related judgments and estimates that affect the preparation of our financial statements is set forth in our consolidated financial statements for the year ended December 31, 2025. Such policies are unchanged.

 

New Accounting Standards

 

There were no new standards recently issued which would have an impact on our operations or disclosures.

 

Results of Operations for the Three Months Ended March 31, 2026 Compared with the Three Months Ended March 31, 2025

 

The table below sets forth the Net Revenue, Cost of Goods Sold, Operating Expenses, Other Income and Expenses, Tax Expense and Net Income by segment for each of the respective periods and a comparison period over period.

 

   Three Months Ended March 31, 2026   Three Months Ended March 31, 2025   Three Months Ended March 31, 2026
Compared to Three Months Ended March 31, 2025
 
   Consolidated   US   Taiwan   Consolidated   US   Taiwan   Consolidated       US       Taiwan     
Revenues   1,494,174    23,482    1,470,692    1,474,576    238,426    1,236,150    19,598    1%   (214,944)   (90)%   234,542    19%
Cost of Goods Sold   998,966    24,186    974,780    1,186,365    183,628    1,002,737    (187,399)   (16)%   (159,442)   (87)%   (27,957)   (3)%
Gross Profit   495,208    (704)   495,912%   288,211    54,798    233,413    206,997    71%   (55,502)   (101)%   262,499    112%
    33%   (3)%   34%   20%   23%   19%   13%   65%   (26)%   (113)%   15%   79%
Total Operating Expenses   1,060,910    859,202    201,708    1,123,770    941,813    181,957    (62,860)   (6)%   (82,611)   (9)%   19,751    11%
Income (Loss) from Operations   (566,691)   (859,908)   293,215    (835,559)   (887,015)   51,456    268,868    (32)%   27,107    (3)%   241,759    470%
Interest Income and Other (Expenses), net   32,871    26,981    5,890    41,887    39,141    2,746    (9,016)   (22)%   (12,160)   (31)%   3,144    114 
Net loss   (532,831)   (832,925)   300,094    (793,672)   (847,874)   54,202    260,841    (33)%   14,949    (2)%   245,892    94%

 

The increase in revenue for the three months ended March 31, 2026 compared with the same period in 2025 is attributable primarily to increased equipment sales from Iveda Taiwan as a result of delivery timing related to long-term government contracts.

 

The increase in overall gross margin was primarily attributed to the higher margin contract sales in Taiwan.

 

The net decrease in operating expenses in the three months ended March 31, 2026 compared with the same period in 2025 is due primarily to reduction in general operation expenses in the US based operations during this period.

 

A majority of the decrease in loss from operations was primarily due to increased gross margins and reduction in operating expenses.

 

The decrease in net loss was primarily due to a reduction in operating expenses for the three months ended March 31, 2026 compared to the same period in 2025.

 

Liquidity and Capital Resources

 

As of March 31, 2026, we had cash and cash equivalents of $5.7 million compared to $5.2 million as of December 31, 2025. This increase in our cash and cash equivalents for the three months ended March 31, 2026 is related to the sale of common stock offset by the operating losses during the three months ended March 31, 2026. There are no legal or economic factors that materially impact our ability to transfer funds between our U.S.-based and Taiwan-based segments.

 

22
 

 

Net cash used in operating activities during the three months ended March 31, 2026 was ($0.9) million compared to ($0.1) million net cash used during the three months ended March 31, 2025. Net cash used in operating activities for the three months ended March 31, 2026 consisted primarily of the net loss of ($0.5) million. Net cash used by operating activities for the three months ended March 31, 2025 consisted primarily of the net loss of ($0.8) million.

 

Net cash used in investing activities for the three months ended March 31, 2026 and 2024 were negligible.

 

Net cash provided by financing activities for the three months ended March 31, 2026 were $1.4 million compared with $0 million provided during the three months ended March 31, 2025. Net cash provided by financing activities in 2026 included $1.6 million from the sale of stock in a direct offering managed by H.C.Wainwright.

 

We have experienced significant operating losses since our inception. At December 31, 2025, we had approximately $38 million in net operating loss carryforwards available for federal income tax purposes, which will begin to expire in 2025. We did not recognize any benefit from the federal net operating loss carryforwards in 2025 or 2024. We also had approximately $12.0 million in state net operating loss carryforwards, which expire after five years.

 

Pursuant to the Internal Revenue Code of 1986, as amended (“IRC”), specifically Sections 382 and 383, the Company’s ability to use tax attribute carryforwards to offset future taxable income is limited if the Company experiences a cumulative change in ownership of more than 50% within a three-year testing period. The Company has not completed an ownership change analysis pursuant to IRC Section 382 therefore the ability to offset taxable income in the future may be impacted by ownership changes occurring prior to December 31, 2025. If ownership changes within the meaning of IRC Section 382 occur in the future, the amount of remaining tax attribute carryforwards available to offset future taxable income and income tax expense in future years may be significantly restricted or eliminated. Further, the Company’s deferred tax assets associated with such tax attributes could be significantly reduced or eliminated upon realization of an ownership change within the meaning of IRC Section 382. If eliminated, the related asset would be removed from the deferred tax asset schedule, with a corresponding reduction in the valuation allowance. Additionally, limitations on the utilization of the Company’s tax attribute carryforwards can increase the amount of taxable income and current income tax expense recognized. Due to the existence of the valuation allowance, ownership change limitations that are not significant may not impact the Company’s effective tax rate.

 

We have limited liquidity and have not yet established a stabilized source of revenue sufficient to cover operating costs, based on our current estimated burn rate. Accordingly, our continuation as a going concern is dependent upon our ability to generate greater revenue through increased sales and/or our ability to raise additional funds through the capital markets. No assurance can be given that we will be successful in future financing and revenue-generating efforts. Even if funding is available, we cannot assure investors that it will be available on terms that are favorable to our existing stockholders. Additional funding may be achieved through the issuance of equity or debt securities that could be significantly dilutive to the percentage ownership of our existing stockholders. In addition, these newly issued securities may have rights, preferences, or privileges senior to those of our existing stockholders. Accordingly, such a financing transaction could materially and adversely impact the price of our common stock.

 

Substantially all of our cash is deposited in three financial institutions, two in the United States and one in Taiwan. At times, amounts on deposit in the United States may be in excess of the FDIC insurance limit. Deposits in Taiwan financial institutions are insured by CDIC (“Central Deposit Insurance Corporation”) with maximum coverage of New Taiwan Dollar (NTD) $3 million. At times, amounts on deposit in Taiwan may be in excess of the CDIC insurance limit.

 

Our accounts receivable are unsecured, and we are at risk to the extent such amounts become uncollectible. Although we perform periodic evaluations of our customers’ credit and financial condition, we generally do not require collateral in exchange for our products and services provided on credit.

 

We provide an allowance for doubtful collections, which is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. Payment terms for our U.S.-based segment require prepayment for most products before they are shipped and monthly Sentir licensing fees, which are due in advance on the first day of each month. For our U.S.-based segment, accounts receivable that are more than 120 days past due are considered delinquent. Payment terms for our Taiwan-based segment vary based on our agreements with our customers. Generally, we receive payment for our products and services within one year of commencing the project, except that we retain 5% of the total payment amount and release such amount one year after the completion of the project. For our U.S.-based segment, we had no doubtful accounts receivable allowances for the Three Months ended March 31, 2026 and year ended December 31, 2025. For our Taiwan-based segment, we set up no doubtful accounts receivable allowances for the Three Months ended March 31, 2026 and year ended December 31, 2025. We deem the rest of our accounts receivable to be collectible based on certain factors, including the nature of the customer contracts and past experience with similar customers. Delinquent receivables are written off based on individual credit valuation and specific circumstances of the customer, and we generally do not charge interest on past due receivables.

 

Effects of Inflation

 

For the periods for which financial information is presented, we do not believe that the current levels of inflation in the United States have had a significant impact on our operations. Likewise, we do not believe that the current levels of inflation in Taiwan have had a significant impact on the operations of Iveda Taiwan.

 

Off Balance Sheet Arrangements

 

We do not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not have any undisclosed borrowings or debt, and we have not entered into any synthetic leases. We are, therefore, not materially exposed to any financing, liquidity, market, or credit risk that could arise if we had engaged in such relationships.

 

23
 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

We are a smaller reporting company as defined by 17 C.F.R. 229 (10)(f)(i) and are not required to provide information under this item.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

 

Our Chief Executive Officer and Principal Financial Officer, after evaluating the effectiveness of our “disclosure controls and procedures” (as defined in the Securities Exchange Act of 1934 Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Annual Report on Form 10-K (the “Evaluation Date”), concluded that as of the Evaluation Date, our disclosure controls and procedures were not effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms.

 

Based on their evaluation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of March 31, 2026, our Principal Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures were not effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.

 

Management’s Annual Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in the Securities  Exchange Act of 1934 Rule 13a-15(f). Our management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control - Integrated Framework, issued by the Committee of Sponsoring Organizations of the Treadway Commission (the “COSO Framework”). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of our financial statements for external purposes in accordance with U.S. GAAP.

 

As of March 31, 2026, management assessed the effectiveness of our internal control over financial reporting based on the criteria for effective internal control over financial reporting established in Internal Control-Integrated Framework of 2013 issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) and SEC guidance on conducting such assessments. Based on that evaluation under this framework, our management concluded that as of March 31, 2026, our internal control over financial reporting was not effective because of the following material weaknesses:

 

The material weaknesses identified include (i) the Company had inadequate segregation of duties consistent with control objectives and (ii) the Company had an insufficient number of personnel with an appropriate level of U.S. GAAP knowledge and experience and ongoing training in the application of U.S. GAAP and SEC disclosure requirements commensurate with the Company’s financial reporting requirements.

 

We are working to remediate the deficiencies and material weaknesses. Our remediation efforts are ongoing, and we will continue our initiatives to implement and document policies, procedures, and internal controls. We have taken steps to enhance our internal control environment and plan to take additional steps to remediate the deficiencies and address material weaknesses. In addition, we continue to evaluate, remediate and improve our internal control over financial reporting, executive management may elect to implement additional measures to address control deficiencies or may determine that the remediation efforts described above require modification. Executive management, in consultation with and at the direction of our Audit Committee, will continue to assess the control environment and the above-mentioned efforts to remediate the underlying causes of the identified material weaknesses.

 

Although we plan to complete this remediation process as quickly as possible, we are unable, at this time to estimate how long it will take; and our efforts may not be successful in remediating the deficiencies or material weaknesses.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting during the Three Months ended March 31, 2026, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Inherent Limitations on Effectiveness of Controls

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed, have inherent limitations. These include the fact that human judgment in decision-making can be faulty and that breakdowns in internal control can occur because of human failures such as simple errors or mistakes or intentional circumvention of the established process. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Because of the inherent limitations of internal control, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process.

 

Changes in Disclosure Controls and Procedures

 

None

 

24
 

 

PART II – OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

From time to time we may become involved in various legal proceedings that arise in the ordinary course of business, including actions related to our intellectual property. Although the outcomes of these legal proceedings cannot be predicted with certainty, we are currently not aware of any such legal proceedings or claims that we believe, either individually or in the aggregate, will have a material adverse effect on our business, financial condition, or results of operations.

 

ITEM 1A. RISK FACTORS.

 

We are a smaller reporting company as defined by 17 C.F.R. 229 (10)(f)(i) and are not required to provide information under this item.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

None.

 

ITEM 3. DEFAULT UPON SENIOR SECURITIES.

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

ITEM 5. OTHER INFORMATION.

 

(a) None.

 

(b) There have been no material changes to the procedures by which security holders may recommend nominees to the Company’s Board of Directors since the Company last provided disclosure in response to the requirements of Item 407(c)(3) of Regulation S-K.

 

(c) Insider Trading Arrangements and Policies

 

During the quarter ended March 31, 2026, no director or officer of the Company “adopted” or “terminated” a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” as each term is defined in Item 408 of Regulation S-K.

 

ITEM 6. EXHIBITS.

 

Exhibit   Description
     
31.1   Certificate of Principal Financial Officer Pursuant to Exchange Act Rule 13a-14(a) or Rule 15d-14(a)
31.2   Certificate of Principal Financial Officer Pursuant to Exchange Act Rule 13a-14(a) or Rule 15d-14(a)
32.1   Certificate of Principal Executive Officer Pursuant to Section 1350
32.2   Certificate of Principal Financial Officer Pursuant to Section 1350
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

25
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  IVEDA SOLUTIONS, INC.
   
Date: May 15, 2026 /s/ David Ly
  David Ly
 

Chief Executive Officer and Chairman

(Principal Executive Officer)

   
  /s/ Robert J. Brilon
  Robert J. Brilon
 

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

26

 

FAQ

How did Iveda (IVDA) perform financially in Q1 2026?

Iveda reported Q1 2026 revenue of $1.49 million and a net loss of $0.53 million. Revenue rose slightly year over year, while the loss narrowed from $0.79 million as gross profit improved and operating expenses declined modestly.

What is Iveda’s cash position and liquidity as of March 31, 2026?

Iveda ended March 31, 2026 with $5.7 million in cash, restricted cash, and equivalents. Management expects this balance to fund its operating plan for at least twelve months from the financial statement issuance date, despite continued operating losses.

How did Iveda’s Q1 2026 revenue mix and major customers look?

Q1 2026 net sales of $1.49 million were dominated by Taiwan, including $0.95 million from Taiwan government. Two Taiwan customers accounted for about 79% of revenue, and one customer represented 84% of accounts receivable at quarter-end.

What equity and warrant activity did Iveda report in Q1 2026?

In February 2026, Iveda raised roughly $2 million gross (about $1.6 million net) via a public offering. Shares outstanding increased to 11,594,027, and total warrants outstanding rose to 13,691,641, mostly new Series X warrants exercisable at $0.35 per share.

Does Iveda have any going concern or control issues in this 10-Q?

Management applied ASC 205-40 and concluded existing cash should support operations for at least twelve months. However, internal control over financial reporting and disclosure controls were deemed not effective due to material weaknesses in segregation of duties and U.S. GAAP expertise.

How did Iveda’s operating expenses and margins change year over year?

Total operating expenses decreased to $1.06 million from $1.12 million in Q1 2025. Gross profit increased to $0.50 million from $0.29 million, reflecting higher-margin Taiwan contracts and lower cost of revenue, which improved overall operating loss compared to last year.